The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

James E. Galvin

Department of Neurology

Washington University

St Louis

USA

[email]@*.wustl.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Neurology, Washington University, St Louis, USA. 2002 - 2010
  • Departments of Neurology, Anatomy and Neurobiology, Alzheimer's Disease Research Center, Washington University School of Medicine, USA. 2001 - 2009

References

  1. Lewy body dementia: caregiver burden and unmet needs. Galvin, J.E., Duda, J.E., Kaufer, D.I., Lippa, C.F., Taylor, A., Zarit, S.H. Alzheimer. Dis. Assoc. Disord (2010) [Pubmed]
  2. The "portable" CDR: translating the clinical dementia rating interview into a PDA format. Galvin, J.E., Meuser, T.M., Coats, M.A., Bakal, D.A., Morris, J.C. Alzheimer. Dis. Assoc. Disord (2009) [Pubmed]
  3. Predictors of physician referral for patient recruitment to Alzheimer disease clinical trials. Galvin, J.E., Meuser, T.M., Boise, L., Connell, C.M. Alzheimer. Dis. Assoc. Disord (2009) [Pubmed]
  4. Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil. Galvin, J.E., Cornblatt, B., Newhouse, P., Ancoli-Israel, S., Wesnes, K., Williamson, D., Zhu, Y., Sorra, K., Amatniek, J. Alzheimer. Dis. Assoc. Disord (2008) [Pubmed]
  5. Psychosocial determinants of intention to screen for Alzheimer's disease. Galvin, J.E., Fu, Q., Nguyen, J.T., Glasheen, C., Scharff, D.P. Alzheimer's & Dementia : J. Alzheimer's Association (2008) [Pubmed]
  6. Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease. Galvin, J.E., Malcom, H., Johnson, D., Morris, J.C. Neurology (2007) [Pubmed]
  7. Patient's rating of cognitive ability: using the AD8, a brief informant interview, as a self-rating tool to detect dementia. Galvin, J.E., Roe, C.M., Coats, M.A., Morris, J.C. Arch. Neurol. (2007) [Pubmed]
  8. Evaluation of cognitive impairment in older adults: combining brief informant and performance measures. Galvin, J.E., Roe, C.M., Morris, J.C. Arch. Neurol. (2007) [Pubmed]
  9. Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra. Galvin, J.E. Acta Neuropathol. (2006) [Pubmed]
  10. Development of a population-based questionnaire to explore psychosocial determinants of screening for memory loss and Alzheimer Disease. Galvin, J.E., Scharff, D.P., Glasheen, C., Fu, Q. Alzheimer. Dis. Assoc. Disord (2006) [Pubmed]
  11. The muscle protein dysferlin accumulates in the Alzheimer brain. Galvin, J.E., Palamand, D., Strider, J., Milone, M., Pestronk, A. Acta Neuropathol. (2006) [Pubmed]
  12. Clinical phenotype of Parkinson disease dementia. Galvin, J.E., Pollack, J., Morris, J.C. Neurology (2006) [Pubmed]
  13. Cognitive change in Parkinson disease. Galvin, J.E. Alzheimer. Dis. Assoc. Disord (2006) [Pubmed]
  14. Validity and reliability of the AD8 informant interview in dementia. Galvin, J.E., Roe, C.M., Xiong, C., Morris, J.C. Neurology (2006) [Pubmed]
  15. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Galvin, J.E., Powlishta, K.K., Wilkins, K., McKeel, D.W., Xiong, C., Grant, E., Storandt, M., Morris, J.C. Arch. Neurol. (2005) [Pubmed]
  16. The AD8: a brief informant interview to detect dementia. Galvin, J.E., Roe, C.M., Powlishta, K.K., Coats, M.A., Muich, S.J., Grant, E., Miller, J.P., Storandt, M., Morris, J.C. Neurology (2005) [Pubmed]
  17. Expression profiling in the aging brain: a perspective. Galvin, J.E., Ginsberg, S.D. Ageing Res. Rev. (2005) [Pubmed]
  18. Neurodegenerative diseases: pathology and the advantage of single-cell profiling. Galvin, J.E. Neurochem. Res. (2004) [Pubmed]
  19. Expression profiling and pharmacotherapeutic development in the central nervous system. Galvin, J.E., Ginsberg, S.D. Alzheimer. Dis. Assoc. Disord (2004) [Pubmed]
  20. Dementia with Lewy bodies. Galvin, J.E. Arch. Neurol. (2003) [Pubmed]
  21. Familial dementia with Lewy bodies: clinicopathologic analysis of two kindreds. Galvin, J.E., Lee, S.L., Perry, A., Havlioglu, N., McKeel, D.W., Morris, J.C. Neurology (2002) [Pubmed]
  22. Synucleinopathies: clinical and pathological implications. Galvin, J.E., Lee, V.M., Trojanowski, J.Q. Arch. Neurol. (2001) [Pubmed]
 
WikiGenes - Universities